Viewing Study NCT02828020


Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2026-02-24 @ 12:25 AM
Study NCT ID: NCT02828020
Status: COMPLETED
Last Update Posted: 2019-01-03
First Post: 2016-07-07
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy, Safety, and Tolerability Study of Oral Ubrogepant in the Acute Treatment of Migraine
Sponsor: Allergan
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Migraine, With or Without Aura View
Keywords: